Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 646

    Article Cited by others

ORIGINAL ARTICLE

Evaluating the utility of intralipid infusion to improve live birth rates in patients with recurrent pregnancy loss or recurrent implantation failure

Martini Anne E, Jasulaitis Sue, Fogg Louis F, Uhler Meike L, Hirshfeld-Cytron Jennifer E

Year : 2018| Volume: 11| Issue : 3 | Page no: 261-268

   This article has been cited by
 
1 Post-hoc evaluation of peripheral blood natural killer cell cytotoxicity in predicting the risk of recurrent pregnancy losses and repeated implantation failures
Maria Dinorah Salazar, Wen Juan Wang, Annie Skariah, Qiaohua He, Kathryn Field, Margaret Nixon, Rachel Reed, Svetlana Dambaeva, Kenneth Beaman, Alice Gilman-Sachs, Joanne Kwak-Kim
Journal of Reproductive Immunology. 2022; 150: 103487
[Pubmed]  [Google Scholar] [DOI]
2 Uterine natural killer cells: from foe to friend in reproduction
Indra Díaz-Hernández, Diana Alecsandru, Juan Antonio García-Velasco, Francisco Domínguez
Human Reproduction Update. 2021; 27(4): 720
[Pubmed]  [Google Scholar] [DOI]
3 Intralipid treatment for women with reproductive failures
Carolyn B. Coulam
American Journal of Reproductive Immunology. 2021; 85(4)
[Pubmed]  [Google Scholar] [DOI]
4 Lipid emulsion therapy in women with recurrent pregnancy loss and repeated implantation failure: The role of abnormal natural killer cell activity
Paula Renata Bueno Campos Canella, Ricardo Barini, Patrícia de Oliveira Carvalho, Daniela Soares Razolli
Journal of Cellular and Molecular Medicine. 2021; 25(5): 2290
[Pubmed]  [Google Scholar] [DOI]
5 The Role of Uterine Natural Killer Cells on Recurrent Miscarriage and Recurrent Implantation Failure: From Pathophysiology to Treatment
Konstantinos Sfakianoudis, Anna Rapani, Sokratis Grigoriadis, Agni Pantou, Evangelos Maziotis, Georgia Kokkini, Chrysanthi Tsirligkani, Stamatis Bolaris, Konstantinos Nikolettos, Margarita Chronopoulou, Konstantinos Pantos, Mara Simopoulou
Biomedicines. 2021; 9(10): 1425
[Pubmed]  [Google Scholar] [DOI]
6 Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art
Kilian Vomstein, Katharina Feil, Laura Strobel, Anna Aulitzky, Susanne Hofer-Tollinger, Ruben-Jeremias Kuon, Bettina Toth
Journal of Clinical Medicine. 2021; 10(4): 869
[Pubmed]  [Google Scholar] [DOI]
7 Efficacy of intralipid administration to improve in vitro fertilization outcomes: A systematic review and meta-analysis
E Jung Han, Hye Nam Lee, Min Kyoung Kim, Sang Woo Lyu, Woo Sik Lee
Clinical and Experimental Reproductive Medicine. 2021; 48(3): 203
[Pubmed]  [Google Scholar] [DOI]
8 “Add-Ons” for Assisted Reproductive Technology: Do Patients Get Honest Information from Fertility Clinics’ Websites?
Valentina Galiano, Raoul Orvieto, Ronit Machtinger, Ravit Nahum, Emanuele Garzia, Patrizia Sulpizio, Anna Maria Marconi, Daniel Seidman
Reproductive Sciences. 2021; 28(12): 3466
[Pubmed]  [Google Scholar] [DOI]
9 Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review
Léo Plaçais, Kamilla Kolanska, Yasmine Ben Kraiem, Jonathan Cohen, Ludovic Suner, Marie Bornes, Lucie Sedille, Audrey Rosefort, Emmanuel Mathieu D’Argent, Lise Selleret, Noémie Abisror, Catherine Johanet, Nathalie Chabbert Buffet, Emile Darai, Jean Marie Antoine, Olivier Fain, Gilles Kayem, Arsène Mekinian
European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020; 252: 100
[Pubmed]  [Google Scholar] [DOI]
10 The effect of intralipid on pregnancy outcomes in women with previous implantation failure in in vitro fertilization/intracytoplasmic sperm injection cycles: A systematic review and meta-analysis
Ping Zhou, Hanglin Wu, Xiaona Lin, Shasha Wang, Songying Zhang
European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020; 252: 187
[Pubmed]  [Google Scholar] [DOI]

 

Read this article